Hwang Jawon, Moon Jisu, Kim Ki-Yoon, Park Sung Hyun, Cho Minah, Kim Yoo Min, Hyung Woo Jin, Kim Hyoung-Il
Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea; Gastric Cancer Center, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea.
Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.
Eur J Surg Oncol. 2025 Aug;51(8):110137. doi: 10.1016/j.ejso.2025.110137. Epub 2025 May 8.
Reduced-port robotic distal gastrectomy (REPRODG) combines reduced-port surgery with robotic assistance to further optimize surgical outcomes. While the advantages of both reduced-port and robotic approaches over conventional laparoscopic surgery remain controversial, evaluating these techniques together may reveal potential benefits not observed when assessed separately. This study aimed to compare the surgical and oncologic outcomes of REPRODG to those of conventional laparoscopic distal gastrectomy (CLDG).
We conducted a retrospective analysis of 1865 patients with gastric cancer who underwent either REPRODG or CLDG between January 2015 and December 2018. Utilizing 1:1 propensity score matching, we compared short- and long-term outcomes between the groups.
A total of 174 matched pairs of REPRODG and CLDG patients were analyzed. The REPRODG group demonstrated a shorter hospital stay (p = 0.006) and faster time to the first flatus (p = 0.001), and a lower incidence of pulmonary complications (p = 0.044) compared to the CLDG group. No significant differences were observed in overall and recurrence-free survival between the two groups (p = 0.739 and 0.564, respectively).
This study suggests that REPRODG may provide better short-term surgical outcomes to CLDG, particularly faster postoperative recovery, while maintaining comparable oncologic outcomes. Integrating robotic technology into reduced-port distal gastrectomy may further optimize postoperative recovery.
减孔机器人远端胃癌切除术(REPRODG)将减孔手术与机器人辅助相结合,以进一步优化手术效果。虽然减孔手术和机器人手术相对于传统腹腔镜手术的优势仍存在争议,但将这些技术结合起来评估可能会发现单独评估时未观察到的潜在益处。本研究旨在比较REPRODG与传统腹腔镜远端胃癌切除术(CLDG)的手术和肿瘤学结果。
我们对2015年1月至2018年12月期间接受REPRODG或CLDG的1865例胃癌患者进行了回顾性分析。利用1:1倾向评分匹配,我们比较了两组的短期和长期结果。
共分析了174对匹配的REPRODG和CLDG患者。与CLDG组相比,REPRODG组住院时间更短(p = 0.006),首次排气时间更快(p = 0.001),肺部并发症发生率更低(p = 0.044)。两组的总生存率和无复发生存率均无显著差异(分别为p = 0.739和0.564)。
本研究表明,REPRODG可能比CLDG提供更好的短期手术效果,尤其是术后恢复更快,同时保持相当的肿瘤学效果。将机器人技术整合到减孔远端胃癌切除术中可能会进一步优化术后恢复。